US Food and Drug Administration Regulatory Programs for Innovative Technologies

被引：4
|
作者：
Brodie, Frank [1 ]
Nguyen, Tieuvi [2 ]
Eydelman, Malvina [2 ]
机构：
[1] Stanford, Byers Eye Inst, Palo Alto, CA USA
[2] US FDA, Off Prod Evaluat & Qual, Off Ophthalm Anesthesia Resp & Ear Nose & Throat, Silver Spring, MD USA
来源：
JAMA OPHTHALMOLOGY | 2019年 / 137卷 / 12期
关键词：
D O I：
10.1001/jamaophthalmol.2019.3708
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
This Viewpoint describes US Food and Drug Administration programs designed with the aim of enhancing and expediting the regulatory process to bring ophthalmic devices to patients more rapidly and efficiently.
引用
收藏
页码：1349 / 1350
页数：2
相关论文
共 50 条
  • [1] Regulatory science within US Food and Drug Administration
    Patwardhan, Dinesh
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [2] The US Food and Drug Administration and probiotics: Regulatory categorization
    Degnan, Frederick H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2008, 46 : S133 - S136
  • [3] Regulatory Action on Rosiglitazone by the US Food and Drug Administration
    Woodcock, Janet
    Sharfstein, Joshua M.
    Hamburg, Margaret
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (16): : 1489 - 1491
  • [4] My career as a regulatory scientist at US Food and Drug Administration
    Jackson, Lauren
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 255
  • [5] Demystifying the US Food and Drug Administration: Understanding Regulatory Pathways
    Naghshineh, Nima
    Brown, Spencer
    Cederna, Paul S.
    Levi, Benjamin
    Lisiecki, Jeffrey
    D'Amico, Richard A.
    Hume, Keith M.
    Seward, William
    Rubin, J. Peter
    [J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 2014, 134 (03) : 559 - 569
  • [6] US Food and Drug Administration regulatory updates in neuro-oncology
    Mehta, Gautam U.
    Barone, Amy K.
    Bradford, Diana
    Larkins, Erin
    Kim, Janice
    Pai-Scherf, Lee
    Jaigirdar, Adnan
    Shah, Mirat
    Wedam, Suparna
    Amiri-Kordestani, Laleh
    Theoret, Marc R.
    Pazdur, Richard
    Beaver, Julia A.
    Singh, Harpreet
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2021, 153 (03) : 375 - 381
  • [7] The clinical pharmacogeneticist: An emerging regulatory scientist at the US Food and Drug Administration
    Issam Zineh
    Janet Woodcock
    [J]. Human Genomics, 4 (4)
  • [8] US Food and Drug Administration - A science-based regulatory agency
    Schwetz, BA
    [J]. JOURNAL OF AOAC INTERNATIONAL, 2001, 84 (01) : 171 - 175
  • [9] US Food and Drug Administration regulatory approaches for xenotransplantation products and xenografts
    Arcidiacono, Judith
    [J]. XENOTRANSPLANTATION, 2020, 27 (06) : CP5 - U7
  • [10] US Food and Drug Administration regulatory updates in neuro-oncology
    Gautam U. Mehta
    Amy K. Barone
    Diana Bradford
    Erin Larkins
    Janice Kim
    Lee Pai-Scherf
    Adnan Jaigirdar
    Mirat Shah
    Suparna Wedam
    Laleh Amiri-Kordestani
    Marc R. Theoret
    Richard Pazdur
    Julia A. Beaver
    Harpreet Singh
    [J]. Journal of Neuro-Oncology, 2021, 153 : 375 - 381
12345